Biomerics Appoints Arun Mohan as New Chief Executive Officer

SALT LAKE CITY, Oct. 6, 2025 /PRNewswire/ -- Biomerics, a leading vertically integrated contract manufacturer for the interventional medical device market, today announced the appointment of Arun Mohan as Chief Executive Officer. Founder and current CEO Travis Sessions will transition into the role of Chairman of the Board, ensuring continuity in vision and strategy.

"This is a defining moment in Biomerics' 30-year journey," said Sessions. "Our success has always been rooted in innovation, manufacturing excellence and a relentless focus on serving our customers. Arun has the leadership, vision and proven track record to take Biomerics to the next level. With the full support of the board, I am confident that under his leadership, we will continue to deliver transformative solutions for patients while expanding our global footprint. I look forward to working alongside him as Chairman."

"I am humbled and honored to lead Biomerics into its next chapter," said Mohan. "Our mission is clear: to improve and save lives. To achieve this, we will place our customers at the center, invest in our people and advance manufacturing excellence as the foundation of everything we do. Together, we will innovate boldly, grow responsibly, and build a company that not only leads in medtech manufacturing, but also inspires pride in every employee and confidence in every customer."

As CEO, Mohan will serve on the Biomerics board of directors and be responsible for the company's global business operations, financial performance and strategic growth initiatives. He previously served as President of Biomerics' Micro Metals Division, where he built a high-performing team that delivered exceptional results in customer satisfaction, operational efficiency and scalable growth. His leadership philosophy centers on customer centricity, employee empowerment and innovation-driven execution.

Sessions, who founded Biomerics in 1994, will remain deeply engaged as Chairman, advising Mohan on strategic initiatives, including future mergers and acquisitions. Under Sessions's leadership, Biomerics has grown from a single-site startup to a trusted partner with over 3,000 employees across 12 locations in the United States, the Dominican Republic and Costa Rica, serving the world's leading interventional device companies at scale.

About Biomerics

Founded in 1994, Biomerics is a leading vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a vertically integrated partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs globally. Biomerics provides engineering design and development services, technology transfer manufacturing services, and contract manufacturing services — including sterilization and packaging — for medical device components, subassemblies and finished medical devices. Through nine locations in the United States, two in Costa Rica and one in the Dominican Republic, Biomerics meets customers' immediate and long-term strategic needs. With comprehensive engineering Centers of Excellence, Biomerics is a leader in performance materials, interventional medical plastics, precision extrusion, micromachining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters and steerables, guidewires, image guided intervention, micro-overmolding, micro precision stamping, metal injection molding (MIM), and complex microassembly and finished device assembly. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is FDA registered and compliant with FDA 21 CFR Part 820.

Daniel Craven
Director, Marketing & Communications
Biomerics LLC
Phone: +1 888-874-7787
Email: [email protected]

SOURCE Biomerics, LLC